Neuroscience

Astrocyte dysfunction found to cause cognitive decline

People with dementia have protein build-up in astrocytes that may trigger abnormal antiviral activity and memory loss, according to a preclinical study by a team of Weill Cornell Medicine investigators.

Medications

A promising new antibiotic for resistant gonorrhea

A new preclinical drug candidate developed by scientists at the Hackensack Meridian Center for Discovery and Innovation (CDI) shows great promise in eradicating the bacteria causing gonorrhea, according to a new publication.

Diseases, Conditions, Syndromes

Study reveals how COVID damages the heart

University of Queensland researchers have discovered how COVID-19 damages the heart, opening the door to future treatments.

Diseases, Conditions, Syndromes

Pumping the brakes on autoimmune disease

Researchers at Sanford Burnham Prebys, collaborating with scientists from Eli Lilly and Company, have revealed the structure and function of a drug called LY3361237, which can reduce the harmful activity of the immune system ...

Diseases, Conditions, Syndromes

SARS-CoV-2 protein caught severing critical immunity pathway

Over the past two years, scientists have studied the SARS-CoV-2 virus in great detail, laying the foundation for developing COVID-19 vaccines and antiviral treatments. Now, for the first time, scientists at the Department ...

Diseases, Conditions, Syndromes

Surprise discovery redirects efforts for treatment of liver disease

WEHI researchers have revealed that common liver diseases are not driven by inflammatory cell death as previously thought, resolving a long-standing controversy in gastroenterology and pointing to a new direction for treatment.

page 20 from 40